- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical applications of nanomedicines in lung cancer treatment
Authors
Keywords
Nanomedicine, Lung cancer, NSCLC, Drug delivery, Cancer treatment
Journal
Acta Biomaterialia
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-08
DOI
10.1016/j.actbio.2020.12.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
- (2020) Robert Jotte et al. Journal of Thoracic Oncology
- EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX ‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes
- (2020) Kyriaki Tzogani et al. ONCOLOGIST
- Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy
- (2020) Mohammad Norouzi et al. Nanomaterials
- Gold Nanoparticles in Glioma Theranostics
- (2020) Mohammad Norouzi PHARMACOLOGICAL RESEARCH
- Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles
- (2020) Mohammad Norouzi et al. Scientific Reports
- Nanotechnology in the diagnosis and treatment of lung cancer
- (2019) Alexander M. Cryer et al. PHARMACOLOGY & THERAPEUTICS
- Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy
- (2019) Xiaojie Zhu et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
- (2019) Anubhab Mukherjee et al. Cancers
- Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review
- (2019) A. Sun et al. Current Oncology
- Reversible stimuli-responsive nanomaterials with on-off switching ability for biomedical applications
- (2019) Teresa Alejo et al. JOURNAL OF CONTROLLED RELEASE
- Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study
- (2018) Charu Aggarwal et al. Clinical Lung Cancer
- α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer
- (2018) Dong Mei et al. DRUG DELIVERY
- Recent advances in brain tumor therapy: application of electrospun nanofibers
- (2018) Mohammad Norouzi DRUG DISCOVERY TODAY
- Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting
- (2018) Rui Ran et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Cancer cell-selective, clathrin-mediated endocytosis of aptamerdecorated nanoparticles
- (2018) Shira Engelberg et al. Oncotarget
- Salinomycin-loaded Nanofibers for Glioblastoma Therapy
- (2018) Mohammad Norouzi et al. Scientific Reports
- An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
- (2018) Shin-Wha Lee et al. Cancer Research and Treatment
- Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).
- (2018) Luis G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cloaking nanoparticles with protein corona shield for targeted drug delivery
- (2018) Jun Yong Oh et al. Nature Communications
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric micelles: Basic research to clinical practice
- (2017) Anand S. Deshmukh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- P1.03-044 Exploratory Analysis of Lung Cancer Patients in a Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine
- (2017) L. Bazhenova et al. Journal of Thoracic Oncology
- P1.06-047 Management of Patients Aged over 70 Years with Newly Diagnosed Lung Cancer
- (2017) Haider Abbas et al. Journal of Thoracic Oncology
- P1.07-001 A Phase II Study of Etirinotecan Pegol (NKTR-102), a Topoisomerase-I lnhibitor Polymer Conjugate, in Small Cell Lung Cancer
- (2017) Hongbin Chen et al. Journal of Thoracic Oncology
- MA 01.06 A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Chemotherapy-Resistant Small Cell Lung Cancer
- (2017) H. Chen et al. Journal of Thoracic Oncology
- Tumor-associated macrophages and anti-tumor therapies: complex links
- (2016) Cristina Belgiovine et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer
- (2016) Yueling Yuan et al. DRUG DELIVERY
- Injectable hydrogel-based drug delivery systems for local cancer therapy
- (2016) Mohammad Norouzi et al. DRUG DISCOVERY TODAY
- Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery
- (2016) Rahul Pratap Singh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- PS01.04: A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Refractory Brain Metastases and Advanced Lung Cancer
- (2016) Joel W. Neal et al. Journal of Thoracic Oncology
- Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
- (2016) Kathleen F Pirollo et al. MOLECULAR THERAPY
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
- (2016) Pavan P. Adiseshaiah et al. Nature Reviews Clinical Oncology
- FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1
- (2016) Joohee Sul et al. ONCOLOGIST
- Chemotherapeutic copolymers prepared via the RAFT polymerization of prodrug monomers
- (2016) H. N. Son et al. Polymer Chemistry
- CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
- (2016) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Inhalable liposomal dry powder of gemcitabine-HCl: Formulation, in vitro characterization and in vivo studies
- (2015) Manit Gandhi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation
- (2015) Nathalie Schleich et al. JOURNAL OF CONTROLLED RELEASE
- Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy
- (2015) Bingbing Dai et al. PLoS One
- A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
- (2014) Hee Kyung Ahn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Progress of drug-loaded polymeric micelles into clinical studies
- (2014) Horacio Cabral et al. JOURNAL OF CONTROLLED RELEASE
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer
- (2013) Xu Xu et al. Asian Pacific Journal of Cancer Prevention
- Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy
- (2013) Tanmoy Sadhukha et al. BIOMATERIALS
- Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial
- (2013) Sung Yong Lee et al. Clinical Lung Cancer
- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
- (2013) Darren Lars Stirland et al. JOURNAL OF CONTROLLED RELEASE
- In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
- (2013) Shanthi Ganesh et al. JOURNAL OF CONTROLLED RELEASE
- A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
- (2012) G. S. Jameson et al. CLINICAL CANCER RESEARCH
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
- (2012) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymeric micelles drug delivery system in oncology
- (2012) Jian Gong et al. JOURNAL OF CONTROLLED RELEASE
- Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
- (2012) Charles Lu et al. PLoS One
- Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
- (2011) Xiang-Hong Peng et al. ACS Nano
- A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
- (2011) R Plummer et al. BRITISH JOURNAL OF CANCER
- Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
- (2011) G. P. Stathopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Functionalization of upconverted luminescent NaYF4 : Yb/Er nanocrystals by folic acid–chitosan conjugates for targeted lung cancer cell imaging
- (2011) Qingtao Chen et al. JOURNAL OF MATERIALS CHEMISTRY
- Cancer nanotechnology: application of nanotechnology in cancer therapy
- (2010) Ranjita Misra et al. DRUG DISCOVERY TODAY
- In vitrocytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells
- (2010) Guoqin Niu et al. JOURNAL OF DRUG TARGETING
- Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
- (2009) W. T. Lim et al. ANNALS OF ONCOLOGY
- Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
- (2009) Teni Boulikas EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
- (2009) N. Mylonakis et al. LUNG CANCER
- A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
- (2008) Qian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer
- (2008) L. Prudkin et al. CLINICAL CANCER RESEARCH
- Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats
- (2008) Kazuhiko Hanada et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now